Korean J Obstet Gynecol Search


Korean Journal of Obstetrics & Gynecology 2008;51(6):601-616.
Published online June 1, 2008.
Present status of worldwide clinical trials about uterine cervical cancer.
Seung Cheol Kim
Department of Obstetrics and Gynecology, School of medicine, Ewha Womans University, Seoul, Korea. onco@ewha.ac.kr
Globally, cervical cancer is the second most common malignancy in women and a major cause of morbidity and mortality. Until recently, the greatest strides in reducing cervical cancer mortality have occurred with the advent and implementation of screening programs. Many important advances have also taken place in the diagnosis and treatment of cervical cancer. For young women who preserve fertility, radical trachelectomy was introduced. With advancing laparoscopic technique, radical hysterectomy using laparoscopy became operative. In radiation therapy, image-guided brachytherapy and intensity-modulated radiation therapy were introduced to optimized therapeutic effect and to reduce complication. Currently, in advanced stage cervical cancer, cisplatin-based concurrent chemoradiation was regarded as standard treatment. There is no consensus on optimal treatment modality in bulky IB2 and IIA tumor and metastatic, recurrent cancer.
Key Words: Cervical cancer, Clinical trials, Management

Article category

Browse all articles >


Browse all articles >

Editorial Office
4th Floor, 36 Gangnam-daero 132-gil, Gangnam-gu, Seoul 06044, Korea
Tel: +82-2-3445-2382    Fax: +82-2-3445-2440    E-mail: journal@ogscience.org                

Copyright © 2021 by Korean Society of Obstetrics and Gynecology. All rights reserved.

Developed in M2PI

Close layer
prev next